1.0E2Phttps://cep.health/e2p Sickle Cell Disease — E2Prich600338<blockquote class="wp-embedded-content" data-secret="ewVFi2vWG6"><a href="https://cep.health/e2p/acute-care-tools/sickle-cell-disease/"> Sickle Cell Disease</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cep.health/e2p/acute-care-tools/sickle-cell-disease/embed/#?secret=ewVFi2vWG6" width="600" height="338" title="“ Sickle Cell Disease” — E2P" data-secret="ewVFi2vWG6" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://cep.health/e2p/wp-includes/js/wp-embed.min.js
</script>
SCD is a priority topic and a new use case within the E2P program for acute care hospitals. Sickle Cell Disease (SCD) is a group of inherited red blood cell disorders that cause severe body pain and damage. More than 3,500 Ontarians are living with the incurable disease, which primarily affects Black and racialized people from Africa, the Caribbean Mediterranean, the Middle East, South America and South Asia. However, many people with SCD experience delayed care, misdiagnosis and undertreatment, due to inconsistent approaches to treatment, lack of training and systemic racism.https://cep.health/e2p/wp-content/uploads/OHA-SCD-Article.png15821902